Market Performance: Gujarat Kidney Makes a Calm but Confident Entry
The Gujarat Kidney share price opened on a steady note, offering investors a decent start on its first day on the stock market today. In a market that remained watchful rather than aggressive, the stock’s listing managed to hold attention without creating excessive noise.
Gujarat Kidney And Super Speciality made its debut on Tuesday after seeing healthy interest during its IPO window between December 22 and December 24, where the issue was subscribed 5.21 times. This level of participation set the tone for what followed on listing day.
On the National Stock Exchange (NSE), Gujarat Kidney shares listed at ₹120 per share, marking a 5.26% premium over the upper end of the IPO price band.
On the BSE, the stock entered the market at ₹120.75 per share, translating into a 5.92% premium.
This performance placed the Gujarat Kidney share price comfortably above its IPO pricing, reflecting measured optimism rather than speculative excitement.
Main News: Listing Beats Muted Pre-Listing Buzz
The Gujarat Kidney share price debut turned out stronger than what informal market cues had suggested earlier. Ahead of the listing, the expectations were muted, with indications pointing toward a flat opening.
However, once trading began, the stock managed to surprise on the upside.
Here’s how the numbers lined up:
- IPO price band: ₹108–₹114 per share
- NSE listing price: ₹120 per share
- BSE listing price: ₹120.75 per share
- IPO subscription: 5.21 times
- Issue size: ₹251 crore
This divergence between muted pre-listing buzz and actual market performance highlights how investor sentiment can shift once shares hit the secondary market. The stock market today rewarded the company with a stable, respectable entry rather than a volatile start.
Company Details: Market Capitalisation After Listing
Post-listing, Gujarat Kidney And Super Speciality entered the market with a sizeable footprint.
- Market capitalisation after listing: ₹952.03 crore
The valuation reflects how the market chose to price the company at the close of its first trading session. While not aggressive, it positions Gujarat Kidney as a mid-sized healthcare player that has now successfully transitioned into a listed entity.
The listing across both NSE and BSE ensured broad market participation from day one, adding liquidity and visibility to the Gujarat Kidney share price on the stock market today.
Summary: What the Listing Signals?
The Gujarat Kidney share price debut tells a simple, clear story.
The IPO attracted reasonable demand. The listing delivered a single-digit premium. And the stock entered the market without sharp swings.
In short:
- The stock listed above the IPO price band
- Gains stayed within a 5–6% range
- Market capitalisation settled at ₹952.03 crore
- Listing was better than informal pre-listing signals
For the stock market today, this was a reminder that not every debut needs fireworks. Sometimes, a calm and confident start is exactly what defines a stable entry into the listed space.
As trading continues, all eyes will naturally remain on how the Gujarat Kidney share price behaves in the coming sessions—but its first step onto the exchanges has been firmly planted.
Source: Moneycontrol
Easy & quick
Leave A Comment?